Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vision; Disorder, Loss”

233 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 233 results

Not applicableLooking for participantsNCT07185971
What this trial is testing

PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery

Who this might be right for
Homonymous HemianopsiaHomonymous Quadrantanopia
NeuroAEye LLC 30
Not applicableStudy completedNCT06176625
What this trial is testing

Sight and Hearing Investigation Into Effects on Delirium

Who this might be right for
Hearing LossHearing Loss, Age-RelatedHearing Disability+14 more
Johns Hopkins University 1,543
Testing effectiveness (Phase 2)Study completedNCT01838655
What this trial is testing

Nitisinone for Type 1B Oculocutaneous Albinism

Who this might be right for
AlbinismVision Loss
National Eye Institute (NEI) 5
Post-approval studies (Phase 4)Study completedNCT04679935
What this trial is testing

Efficacy and Safety of Two Different Brolucizumab 6 mg Dosing Regimens in Neovascular Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 52
Not applicableLooking for participantsNCT02435940
What this trial is testing

Inherited Retinal Degenerative Disease Registry

Who this might be right for
Eye Diseases HereditaryRetinal DiseaseAchromatopsia+25 more
Foundation Fighting Blindness 20,000
Large-scale testing (Phase 3)Study completedNCT02652767
What this trial is testing

Efficacy Study of GS010 for the Treatment of Vision Loss up to 6 Months From Onset in LHON Due to the ND4 Mutation

Who this might be right for
Optic, Atrophy, Hereditary, Leber
GenSight Biologics 39
Not applicableStudy completedNCT05419063
What this trial is testing

Accessible Weight Loss for Adults With Low Vision: A Feasibility Study

Who this might be right for
Overweight and Obesity
Towson University 28
Post-approval studies (Phase 4)UnknownNCT01125306
What this trial is testing

Efficiency of XAL-EASE Device in Glaucoma and/or Ocular Hypertension (OHT) Patients, Treated With Xalatan or Xalacom

Who this might be right for
GlaucomaHypertension
Meir Medical Center 50
Post-approval studies (Phase 4)Study completedNCT05269966
What this trial is testing

Study to Evaluate the Safety and Effectiveness of Intravitreal Injections (IVI) of Brolucizumab in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Novartis Pharmaceuticals 105
Not applicableStudy completedNCT05098236
What this trial is testing

Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage

Who this might be right for
Vision Loss PartialHemianopiaHemianopia Homonymous+2 more
University of Rochester 280
Not applicableLooking for participantsNCT07015034
What this trial is testing

Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice

Who this might be right for
Vision Impairment and BlindnessGlaucomaAge-Related Macular Degeneration+2 more
University of Copenhagen 460
Not applicableStudy completedNCT04804592
What this trial is testing

Investigation in Corneal Sensation and Contact Lens Wear

Who this might be right for
CorneaSense Loss; Cornea
Daniela Nosch 111
Not applicableLooking for participantsNCT03988764
What this trial is testing

Monogenic Diabetes Misdiagnosed as Type 1

Who this might be right for
Diabetes Mellitus, Type 1Monogenic DiabetesNeonatal Diabetes+4 more
McGill University Health Centre/Research Institute of the McGill University Health Centre 5,000
Early research (Phase 1)Study completedNCT00056199
What this trial is testing

EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Who this might be right for
Hippel-Lindau Disease
National Eye Institute (NEI) 5
Not applicableStudy completedNCT03626207
What this trial is testing

Development of Visual Function Evaluation Method (2)

Who this might be right for
Retinitis Pigmentosa
Astellas Pharma Inc 8
Not applicableStudy completedNCT00829036
What this trial is testing

Wayfinding Information Access System for People With Vision Loss

Who this might be right for
Blindness
US Department of Veterans Affairs 24
Not applicableStudy completedNCT03653715
What this trial is testing

Bifocal Contact Lens Study for Adults With Age-Related Near Vision Loss

Who this might be right for
Presbyopia
Clerio Vision, Inc. 30
Testing effectiveness (Phase 2)UnknownNCT04940572
What this trial is testing

Efficacy Study of Daily Administration of VPA in Patients Affected by Wolfram Syndrome

Who this might be right for
Wolfram Syndrome
Centre d'Etude des Cellules Souches 23
Not applicableUnknownNCT03990727
What this trial is testing

Phenotype Correlates Genotype of Inherited Retina Dystrophies, Retinitis Pigmentosa, Con>Rod Dystrophies.

Who this might be right for
Retinitis PigmentosaCone DystrophyUsher Syndromes+1 more
MejoraVisionMD 17,000
Testing effectiveness (Phase 2)Ended earlyNCT05085964
What this trial is testing

An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2
Laboratoires Thea 21
Load More Results